AKT1 and malignant colon neoplasm: Recently Rauch et al. [49] assayed the ability of dextran-coated SPIONs with various surface charges to activate ERK, AKT and EGFR in breast and colon cancer cells either expressing a metastatic RAS mutation or without this mutation.